Who we are

  • An Egyptian joint stock company established in 1997 under the internal investment system in accordance with the provisions of law 230 for the year 1989 & the law 95 for the year 1992
  • 1st batch of production was on September 2001 for the following units:
  1. Solid Dosage Forms: (Tablets, Capsules, Dry powder and Hard gelatin capsules)
  2. Semi-solid dosage forms oral & external: (Creams, Gel & Ointments)
  3. Liquid Dosage forms: (Syrup – Suspension) & Veterinary solution
  • Proudly, we started with thirteen products including but not limited to: (Pono – Hepmarin – Parofen – Univit ...etc.)

Our Mission

“We are committed to provide quality healthcare products and outstanding different services for both sectors of pharmaceutical and animal healthcare products, keeping in mind the top quality of life to the community we are dealing with all over the world.”

Our Vision

“To achieve and maintain a leadership position in the healthcare industry and to be one of the top 30 pharmaceutical companies in the middle east and Africa within the coming 5 years , and to be within the top veterinary production companies in the middle east and this will be achieved via our growth in sales and quality of our pharmaceutical and veterinary brands.”

Sales trends

2002

The total sales of Unipharma (for the three franchises) was 6 million EGP

2016

The total sales of Unipharma (for the three franchises) was 89 million EGP

2017

The total sales of Unipharma (for the three franchises) was 120 million EGP

Unipharma’s Capital

2002

4 Million EGP

2017

44 Million EGP

2020

100 Million EGP

New Expansions with 15 million EGP spent till now

  • Soft Gelatin Capsule Unit
  • Sterile Area Unit

Products in pipeline

  • Antibiotics
  • Antifungals
  • Antihypertensives
  • Corticosteroids
  • Antidepressants
  • Vitamins (Soft Gelatin Capsules)
  • Antiparasitics